U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07004530) titled 'the MCCE vs EGD Trial' on May 27.
Brief Summary: Anaemia is common in patients with acute coronary syndrome (ACS) and is associated with significant recurrent bleeding risk and major adverse cardiovascular event (MACE). Esophageal-gastro-Duodenoscopy (EGD) is commonly used as an initial investigation for anaemia but is often non-diagnostic. Magnetically Controlled Capsule Endoscopy (MCCE) being less invasive and with comparable diagnostic accuracy as EGD, might be used as an alternative initial investigation for anaemia in patients with ACS.
Study Start Date: Sept. 24, 2025
Study Type: INTERVENTIONAL
Condition:
Anaemia
Acute Coro...